FDA Inspection
Servy Institute for Reproductive EndocrinologyServy Institute for Reproductive Endocrinology – FDA Inspection, Oct 30, 2009
Record Details
This FDA Inspection record concerns Servy Institute for Reproductive Endocrinology, with an inspection on October 30, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 30, 2009
- Product Type
- Biologics
View Company Profile
ID · 243857ae-94fc-4343-b18f-2f18509c66c8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 629464
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.47(a)Procedures for all other requirements
- 21 CFR 1271.270(e)Contract firms--identities and responsibilities
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Servy Institute for Reproductive Endocrinology
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 17, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 26, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 11, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 18, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Servy Institute for Reproductive Endocrinology
- FDA Inspection 1063802 - 2018-07-17
- FDA Inspection 971476 - 2016-05-26
- FDA Inspection 887204 - 2014-07-11
- FDA Inspection 754840 - 2011-11-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.